|
Market Closed -
Euronext Paris
10:25:00 19/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 19.10 EUR | 0.00% |
|
+0.26% | -36.96% |
| 17/09 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 23/04 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 33Cr 36Cr 31Cr 28Cr 52Cr 3.4TCr 54Cr 370.31Cr 146.38Cr 1.83TCr 136.41Cr 133.56Cr 5.79TCr | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 28Cr 31Cr 26Cr 24Cr 45Cr 2.91TCr 46Cr 316.87Cr 125.26Cr 1.57TCr 116.73Cr 114.28Cr 4.96TCr | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
12.84% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
| BOIp | Real-time | ||
| BON | Delayed | ||
| 0DTF | Real-time | ||
| BON | Delayed | ||
| BON | Real-time |
| 1 week | +0.26% | ||
| Current month | +2.14% | ||
| 1 month | +5.23% | ||
| 3 months | -27.10% | ||
| 6 months | -28.73% | ||
| Current year | -36.96% |
| 1 week | 18.85 | 19.25 | |
| 1 month | 17.45 | 20.3 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 42.8 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/10/23 | Sell | Director | 1,98,664 | 1.1323% | ||
| 29/10/23 | Sell | Director | 4,62,964 | 2.6387% | ||
| 29/10/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +0.26% | -28.86% | -52.06% | 36Cr | ||
| -1.80% | -5.01% | +29.17% | +126.86% | 1,23200Cr | ||
| -2.12% | -5.79% | +31.89% | +78.17% | 66TCr | ||
| -1.11% | -4.14% | +21.19% | +104.09% | 51TCr | ||
| -1.04% | -1.80% | +28.69% | +68.33% | 38TCr | ||
| -2.86% | -8.85% | +40.92% | +30.45% | 34TCr | ||
| -3.22% | -5.20% | +24.48% | +50.97% | 29TCr | ||
| -2.51% | -4.49% | -2.15% | +31.64% | 28TCr | ||
| -0.94% | -5.83% | +28.45% | +65.75% | 24TCr | ||
| -1.12% | -0.60% | +30.35% | +119.66% | 21TCr | ||
| Average | -1.67% | -2.15% | +20.41% | +62.39% | 41TCr | |
| Weighted average by Cap. | -1.86% | -2.67% | +27.12% | +87.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 49Cr 53Cr 45Cr 41Cr 77Cr 5TCr 80Cr 544.45Cr 215.22Cr 2.7TCr 200.56Cr 196.36Cr 8.51TCr | 50Cr 55Cr 46Cr 42Cr 79Cr 5.13TCr 82Cr 559.57Cr 221.2Cr 2.77TCr 206.13Cr 201.82Cr 8.75TCr |
| Net income | 1.13Cr 1.24Cr 1.05Cr 94.59L 1.78Cr 116.15Cr 1.85Cr 13Cr 5Cr 63Cr 4.66Cr 4.57Cr 197.97Cr | 3.26Cr 3.58Cr 3.02Cr 2.72Cr 5.13Cr 334.47Cr 5.33Cr 36Cr 14Cr 180.53Cr 13Cr 13Cr 570.07Cr |
| Net Debt | -4.97Cr -5.45Cr -4.6Cr -4.15Cr -7.82Cr -509.63Cr -8.12Cr -56Cr -22Cr -275.08Cr -20Cr -20Cr -868.62Cr | -4.79Cr -5.25Cr -4.42Cr -3.99Cr -7.52Cr -490.34Cr -7.82Cr -53Cr -21Cr -264.66Cr -20Cr -19Cr -835.73Cr |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | €19.10 | 0.00% | 258 |
| 18/26/18 | €19.10 | -0.78% | 649 |
| 17/26/17 | €19.25 | +1.32% | 1,291 |
| 16/26/16 | €19.00 | -1.04% | 1,591 |
| 13/26/13 | €19.20 | +0.79% | 1,710 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
















